Healthcare · Medical Instruments & Supplies · NYSE

Stevanato Group SpA (STVN) Stock Price, Analysis & Trade Signals

$15.80+1.44 (+10.03%)

Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.

STVN key stats

Market Cap
$787.39M
P/E Ratio
23.58
Forward P/E
21.14
EPS
0.59
52 Week Range
$12.05 – $24.01
50-Day Avg
19.15
200-Day Avg
17.92
Revenue (TTM)
$1.25B
Revenue Growth (Qtr YoY)
7.6%
Profit Margin
11%
Operating Margin (TTM)
17.9%
Beta
0.8
Volume
1.46M
30-Day Avg Volume
1.12M
CEO
Franco Stevanato
Employees
6,010
IPO Date
Jul 16, 2021

STVN on X: what traders are saying

  • Leandro @Invesquotes · Nov 13, 2026

    Another insider purchase at $STVN This time the former CFO of $WST $274k https://t.co/gLzI7F1d42 https://t.co/SVf78aJp4S

  • Leandro @Invesquotes · Nov 12, 2026

    Don Morel, former $WST CEO that sits on $STVN board, buys $325,000 worth of shares in the open market https://t.co/xxuZXxmNJB

  • Leandro @Invesquotes · Nov 4, 2026

    Looks like some form of capitulation on $STVN today Trading at roughly 11x 2026 EBITDA despite significant tailwinds in the coming years Yes, 2027 is an air pocket and there's basically no catalyst on the horizon, but they'll likely still grow next year while expanding margins

  • Leandro @Invesquotes · Nov 3, 2026

    Published an update on $STVN after today's earnings and drop. You can find it in the usual place https://t.co/DN4yZtZcNY

STVN analyst rating & price target

13 analysts rate STVN Buy on consensus.

2Strong Buy
7Buy
4Hold
0Sell
0Strong Sell

Consensus price target: $19.46 (+23.16% upside from $15.80)

Recent STVN insider transactions

InsiderDateTransactionSharesValue
FEDERICI WILLIAM J
director
Nov 9, 2026Purchase20,000$274.4K
Stocchi Mauro
See Remarks
Sep 28, 2026Sale13,649$293.45K

Stevanato Group SpA annual revenue & net income

Fiscal yearRevenueRevenue YoYNet income
2025$1.26B+3.21%$148M
2024$1.22B+1.72%$129.81M
2023$1.2B+10.34%$160.51M

Stock data for STVN: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics